Estrone sulfatase assay
Cells were washed once with serum-free medium and stored at -20 C until assayed. PBS-sucrose [50 mM phosphate buffer (pH 7.4), 140 mM NaCI, and 250 mM sucrose] was added to each treatment flask (1.5 ml/T25 flask), and the cells were scraped and sonicated on ice using two 3-set cycles with l-min cooling periods (lo-micron amplitude, MSE Soniprep 150, Fisher Scientific UK, Loughborough, Leics, UK). The sonicated cells were centrifuged (10,000 rpm for 5 min), and 0.5 ml of the supernatant was assayed, in duplicate, using [6,7-"Hlestrone sulfate (4 X lo" dpm) adjusted to a final concentration of 20 PM with unlabeled substrate.
After incubation of the substrate with sonicated cell supernatants at 37 C for 60 min, the product formed was isolated from the mixture (1 ml) by extraction with toluene (4 ml). [4-"C]Estrone (7 X 10" dpm) was used to monitor procedural losses. The 3H and 14C contents in the toluene were determined by scintillation spectrometry. Each assay also included tubes without cell supernatants to assess the apparent nonenzymatic hydrolysis of the substrate.
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Morphological assessment and steroid receptor expression
Under maintenance conditions, St-2 cells displayed a fibroblastic spindle-shaped morphology (Fig. 1A) . Immunostaining was positive for vimentin and negative for cytokeratin and LeuMl, confirming their mesenchymal origin (data not shown). In the experiments described here, cells were used within 12 passages of removal from liquid nitrogen, as this provided the most consistent results and overcame the slower growth rate of cells observed at later passages. Treatment of confluent monolayers with 8-bromo-CAMP (0.5 mM), alone (Fig. 1B ) or in combination with MPA (1O-6 M; Fig. lD) , transformed the spindle-shaped cells into cells with abundant cytoplasm, resembling decidual cells (2, 12). Morphological changes were apparent after 2 days of treatment. Large intercellular spaces were formed, and the cells displayed multiple long protrusions on the cell surfaces. Treatment of the cells with MPA alone (Fig. 1C) or with a combination of MPA and E, (data not shown) was unable to elicit this differentiated phenotype. St-2 cells cultured under maintenance conditions were shown to express ER and PR at concentrations of 17.0 t 1.85 and 441 t 46 fmol/mg protein (mean + SEM), respectively.
Induction of PRL secretion and estrone sulfatase activity in St-2 cells
Immunoreactive PRL secreted from St-2 cells and accumulated in the culture medium was first detected after 48-h incubation with 8-bromo-CAMP, alone or in combination with MPA ( Fig. 2A) . MPA, alone or in combination with E, was insufficient to induce PRL production (data not shown). After 96 h, a synergistic effect between 8-bromo-CAMP and MPA on PRL secretion became apparent. The pure antiprogestin, ZK98.299, partially inhibited the synergistic effect of 8-bromo-CAMP plus MPA on PRL production, suggesting involvement of the PR. In parallel with the increase in PRL production in response to 8-bromo-CAMP plus MPA, a 800 (A) 48 hours 96 hours (W marked increase in a further biochemical correlate of endometrial fibroblast differentiation, estrone sulfatase activity, was observed (Fig. 3) .
Effects of 8-bromo-CAMP and MPA on decidual PRL messenger RNA (mRNA) and IGFBP-1 mRNA Several lines of evidence established that the PRL produced by St-2 cells was transcribed from the upstream dPRL promoter that is also used in ESC. Figure 4 illustrates results from Northern blot analysis of St-2 cell total RNA. The PRL transcript [-1.1 kilobases (kb)] detected in St-2 cells was larger than the PRL transcript from human pituitary. It was dose dependently induced by 8-bromo-CAMP (0.2 and 0.5 mM) in the presence of MPA after 3 days, but was undetectable in control cells or cells treated with MPA alone. IGFBP-1 mRNA expression was very low in untreated or MPA treated cells and was induced by the addition of 0.2 and 0.5 mM 8-bromo-CAMP together with MPA (transcript size, -1.6 kb).
A noncoding exon present only in dPRL mRNA (26) was used as the target template for amplification to provide further evidence of expression of the nonpituitary transcript in St-2 cells. Figure 5 shows RT-PCR analysis of St-2 cell RNA, obtained under the indicated treatment conditions, and demonstrates the presence of a 758-bp amplicon consistent with the presence of mRNA transcribed from the distal promoter. The transcript was induced by combination treatment with CAMP and MPA (Fig. 5, lane 4) , confirming the induction observed by Northern analysis (Fig. 4) 
Transient transfection studies
To further confirm the potential activity of the distal PRL promoter in this system, a reporter construct carrying 3000 bp of 5'-flanking DNA to the decidua-specific promoter of the hPRL gene (dPRL-3000/Luc) (25) was transiently transfected into St-2 cells. Reporter gene activity was significantly induced by S-bromo-CAMP but not by MPA, either added alone or in combination with CAMP (Fig. 6 ). The results demonstrate that the dPRL promoter can be activated in St-2 cells and, therefore, support the suggestion that %bromo-CAMP is potentially capable of activating the endogenous distal PRL promoter in St-2 cells. The inability of MPA to synergize with CAMP in activation of the dPRL reporter construct suggests that the synergistic effects on induction of dPRL mRNA and protein may not be entirely explained by transcriptional activation, although this remains to be confirmed. of primary cultures with lymphocytes, macrophages, and epithelial cells have precluded extensive investigation of the molecular events underpinning hormone-induced differentiation (19).
St
Discussion
Immortalization of rat endometrial cells by retrovirus-mediated transfer of SV40 large T antigen has generated cell lines that express steroid hormone receptors and, hence, the potential to exhibit differentiated function in vitro (27, 28). Here we report that it is possible, using a similar approach, to develop a human fibroblast cell line that displays biochemical features of the parental cells. Endometrial cells enriched for fibroblasts were infected, by retrovirus-mediated transfer, with the SV40 large T antigen gene and selected on the basis of resistance to G418 conferred by the neomycin acetyl transferase gene, also carried by the recombinant retrovirus. A polyclonal immortalized cell line that expressed ER and PR was established and termed St-2. Progress in understanding the molecular events that regTo assess the ability of St-2 cells to differentiate under ulate ESC decidualization has been limited by the complexity conditions similar to those used in primary ESC cultures, of hormonal and cellular interactions that regulate this difconfluent monolayers were treated with MPA and CAMP, a ferentiation process' in viva. Primary cultures of enriched ESC stimulus to endometrial stromal cell differentiation in vitro have been used as model systems that can potentially over- (14) . Morphological transformation of spindle-shaped St-2 come some of these inherent limitations. However, the limcells into polygonal, decidua-like cells was observed after 48 ited life span of ESC in vitro and the inevitable contamination h of treatment. Although the phenotypical transformation of these immortalized cells is unlikely to fully mirror ESC decidualization in viva, it coincided with the detection of PRL in the supernatant, expression of IGFBP-1 mRNA, and increased estrone sulfatase activity in the cells. Induction of PRL is a well established biochemical correlate of decidualization in vitro (5). A time-dependent induction of PRL secretion was observed when St-2 cells were treated with B-bromo-CAMP, an effect that was potentiated by the addition of MPA. Evidence of synergy between MPA and B-bromo-CAMP on St-2 cell differentiation was also apparent from the increase in estrone sulfatase activity levels. Enhanced activity of this enzyme has been observed in response to a decidualization stimulus in vitro and in decidual tissue obtained after term pregnancy (7). Arylsulfatase can influence the intracellular levels of E, in endometrial cells by regulation of the conversion of estrone sulfate to estrone, a substrate for E, formation. Benedetto et al. (7) suggested that increased enzymatic activity may result in a preferential estrogenic stimulation of decidualized cells, which could explain why stromal cells, in contrast to epithelial cells, maintain their estrogen-dependent PR levels during the late luteal phase of the cycle and pregnancy (7).
Expression of the hPRL gene in extrapituitary sites, such as decidual stromal cells and lymphocytes, is regulated by an alternative dPRL promoter located approximately 6 kb upstream of the pituitary-specific start site (25, 29) . Activation of the dPRL promoter does not involve Pit-l, which is essential for pituitary PRL expression, and is differentially controlled in human lymphocytes and endometrial stroma. Expression of the hPRL gene in decidual cells results in a PRL message larger than that expressed in pituitary cells because it contains a unique 5'-untranslated exon (exon la) (25, 29) . Accordingly, we demonstrated with Northern blot analysis and RT-PCR, using a 5'-primer specific for exon la sequence, that the nature of the PRL transcript induced in St-2 cells in response to elevation of intracellular CAMP is consistent with it being transcribed from the dPRL promoter. Transient transfection of St-2 cells with a reporter gene construct carrying 3000 bp 5'-flanking DNA to the dPRL and stimulation with B-bromo-CAMP was used to demonstrate that the factors necessary for activation of the distal dPRL promoter were present in St-2 cells. Unstimulated St-2 cells did not activate the promoter and, therefore, displayed properties similar to those of transiently transfected undifferentiated ESC (25). MPA alone was unable to induce de novo expression of either protein or message, but synergized with B-bromo-CAMP to increase the amount of PRL detected in conditioned medium and the apparent abundance of dPRL mRNA. However, such synergy between CAMP and MPA was not observed on the dPRL promoter-reporter construct. Although activation of an extragenomic promoter/reporter construct may not entirely reflect that of the endogenous gene, our observations are in agreement with those of Tang et al. (14) . These workers reported a putative role for CAMP in human PRL gene expression in primary ESC cultures and postulated a posttranscriptional role for MEA in modulating PRL secretion, potentially by inhibition of phosphodiesterase activity, stabilization of PRL mRNA, or other cAMP/progesterone-coordinated mechanisms (14).
The observation that ZK98.299, a pure PR antagonist, could abolish the synergistic effect of MEA on CAMP-induced PRL production demonstrated that MPA exerts its effect through activation of the PR. Interestingly, ZK98.299 also partially antagonized cAMI'-induced PRL secretion in the absence of MPA, suggesting that activation of the protein kinase A pathway by CAMP may result in ligand-independent activation of I'R in St-2 cells. Activation of human PR in the absence of cognate hormone has been reported in response to CAMP (30), although there was no evidence for altered phosphorylation of PR itself (30,31). The mechanism through which alternate signal transduction pathways can activate PR in the absence of steroidal ligand in a cell-specific context and its biological relevance to ESC differentiation remain unresolved.
IGFBP-1 is considered to be a major secretory product of decidual cells and has been widely used as a marker of 
